Mass Spectrometric Analysis TRIZ Cases

Stable isotope dilution enables absolute quantification of endogenous SDF-1 isoforms, resolving sensitivity limitations in complex biological matrices.

Mass spectrometry analysis of alpha-fetoprotein glycopeptides calculates fucosylation rates to identify liver cancer biomarkers.

An isotopic fingerprint generated by elemental analyzer mass spectrometry characterizes cell origin and condition.

Replaces enzymatic ELISA steps with direct mass analysis to reduce assay time and increase throughput.

A histone binding agent isolates cell-free nucleosomes to enrich circulating tumor DNA from biological samples.

Isotopic labeling distinguishes ionizable lipids via mass spectrometry, resolving biomembrane agglomeration challenges.

Dual terminal isotopic labeling separates overlapping N-terminal fragments from unlabeled peptides, enabling accurate quantification in DIA and mPRM proteomics.

Modified cellulose paper enables direct naphthenic acid quantification via paper ionization mass spectrometry, eliminating solvent-intensive extraction steps.

Spike isotopically labeled standards into samples to calculate absolute copy numbers, resolving peptide loss during isolation.

Microdialysis and hydrogen deuterium exchange mass spectrometry identify protein regions driving self-association.

Segmenting tumor-derived exosomes and measuring lipid metabolites improves diagnostic sensitivity over conventional ultrasound surveillance.

Lipidomic biomarkers analyze ceramide and phosphatidylcholine levels to detect heart disease risk.

Correlation model predicts total analyte excretion from short-term urine samples, reducing subject burden and collection time.

A desorption electrospray ionisation source extracts membrane proteins from a solid surface for mass spectrometry analysis.

A bathocuproinedisulfonic acid disodium salt hydrate reagent forms a colored complex with peptides for absorbance measurement at 450 nm to 500 nm.

Calculating a PSA G-index from specific glycan abundances resolves low specificity in the diagnostic gray zone.

Aldehyde derivatization reagent modifies nitrogen-containing compounds to boost ionization efficiency, overcoming low sensitivity detection limits.

Proteomic analysis of serum protein marker profiles detects Type 1 diabetes risk before seroconversion.

A bioinformatics platform identifies glycation proteins and advanced glycation end-products using high-resolution mass spectrometry data.

A breath analysis method using isotope-labeled fatty acids to measure sugar and fatty acid combustion ratios.

A 2-picolylamine derivatization method enables positive ion electrospray mass spectrometry analysis of blood samples.

Acyl chain length analysis in intact phospholipids predicts tumor aggressiveness and therapy response, reducing overtreatment of indolent tumors.

Metabolomic blood analysis classifies endometrial carcinoma using gas chromatography-mass spectrometry and machine learning models.

Analyzing urine metabolite profiles identifies colorectal cancer and polyps without invasive procedures.

Quiescin Q6 resolves BNP specificity issues in patients with renal or chronic heart failure history.

Tandem mass spectrometry quantifies cannabidiol and tetrahydrocannabinol metabolite ratios to distinguish actual marijuana use from product contamination.

Nanostructure-initiator mass spectrometry detects specific lipid abundances in biological samples to identify diseased cells.

Heterologous stable isotope standards eliminate endogenous interference to improve measurement precision in multiplexed mass spectrometry assays.

Derivatized analytes reduce matrix interference and improve detection sensitivity in nanoESI mass spectrometry without chromatographic separation.

A serum-based diagnostic method using lipid metabolic markers to identify non-alcoholic fatty liver disease and distinguish between steatosis and NASH.

Segmenting metabolic intermediates into distinct factors improves diagnostic accuracy for heart failure with preserved ejection fraction.

Ion mobility-mass spectrometry measures collision cross section and mass-to-charge ratio to identify carbohydrate structures.

A selected reaction monitoring assay quantifies tyrosine-protein kinase receptor UFO protein levels using specific peptide markers.

Mass spectrometry detects Alzheimer's biomarkers in cerebrospinal fluid samples for diagnostic assessment.

Quantifying specific serum ether lipids detects age-related plasmalogen deficiency before clinical symptoms emerge, enabling early intervention.

A sampler device retains samples in the ionization region using magnetic fields, preventing displacement by flowing gases during rapid powder analysis.

Hydrogen radical irradiation isolates precursor ions and generates characteristic peak pairs that locate unsaturated bond sites without derivatization.

An isotope-labeled internal standard protein fragment co-captures with target proteins on a solid support before digestion and mass spectrometry analysis.

LC-MS/MS peptide sequencing detects disease-related biomarkers in menstrual fluid samples.

Quaternary ammonium isobaric tags fragment during mass spectrometry to generate reporter ions for glycan analysis.

Isolates tissue-resident extracellular vesicles to identify colon cancer-specific proteins.

Engineered antibody mutations create unique peptide fragments for mass spectrometry quantitation, eliminating cross-reactivity from endogenous human proteins.

Enriches antibody-bound biomarkers to resolve autoantibody interference and improve detection accuracy.

NMR spectroscopy detects metabolite levels to predict hypoxemia risk before clinical symptoms appear.

Buffered mobile phases enable direct quantification of complex molecules, resolving matrix effects and sensitivity limits.

Selective lactone formation at the 2-position of linked sialic acids improves reaction efficiency and specificity in biological settings.

Segmented derivatization reagent improves chromatographic separation and selectivity by resolving labeling efficiency trade-offs in complex biological matrices.